NasdaqGS - Nasdaq Real Time Price USD

Kura Oncology, Inc. (KURA)

5.76
-0.24
(-4.00%)
At close: May 9 at 4:00:01 PM EDT
5.50
-0.26
(-4.51%)
After hours: May 9 at 6:15:56 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
67,991
53,883
0
0
0
Operating Expense
271,434
247,078
165,804
139,865
131,258
Operating Income
-203,443
-193,195
-165,804
-139,865
-131,258
Net Non Operating Interest Income Expense
23,800
21,230
13,173
4,025
792
Pretax Income
-179,643
-171,965
-152,631
-135,840
-130,466
Tax Provision
2,244
2,018
0
0
--
Net Income Common Stockholders
-181,887
-173,983
-152,631
-135,840
-130,466
Diluted NI Available to Com Stockholders
-181,887
-173,983
-152,631
-135,840
-130,466
Basic EPS
-2.09
--
-2.08
-2.03
-1.97
Diluted EPS
-2.09
--
-2.08
-2.03
-1.97
Basic Average Shares
87,038.50
--
73,229
66,990
66,352
Diluted Average Shares
87,038.50
--
73,229
66,990
66,352
Total Expenses
271,434
247,078
165,804
139,865
131,258
Net Income from Continuing & Discontinued Operation
-181,887
-173,983
-152,631
-135,840
-130,466
Normalized Income
-181,887
-173,983
-152,631
-135,840
-130,466
Interest Income
25,403
22,849
14,722
4,254
1,206
Interest Expense
1,603
1,619
1,549
229
414
Net Interest Income
23,800
21,230
13,173
4,025
792
EBIT
-178,040
-170,346
-151,082
-135,611
-130,052
EBITDA
-177,185
-169,498
-150,233
-134,852
-129,494
Reconciled Depreciation
855
848
849
759
558
Net Income from Continuing Operation Net Minority Interest
-181,887
-173,983
-152,631
-135,840
-130,466
Normalized EBITDA
-177,185
-169,498
-150,233
-134,852
-129,494
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/16/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SNDX Syndax Pharmaceuticals, Inc.
10.70
-2.82%
 
REPL Replimune Group, Inc.
7.71
-0.77%
 
IDYA IDEAYA Biosciences, Inc.
17.42
-4.18%
 
DAWN Day One Biopharmaceuticals, Inc.
6.45
-4.59%
 
ADCT ADC Therapeutics SA
1.2700
-0.78%
 
RVMD Revolution Medicines, Inc.
40.42
-3.56%
 
JANX Janux Therapeutics, Inc.
25.56
-3.07%
 
RCUS Arcus Biosciences, Inc.
8.28
-2.93%
 
BCYC Bicycle Therapeutics plc
8.34
+1.96%
 
XNCR Xencor, Inc.
8.33
-5.23%